Ilaris - canakinumab
Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0078-0582 |
| Proprietary Name: | Ilaris |
| Suffix: | |
| Non-Proprietary Name: | canakinumab |
| Dosage Form: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Method: | SUBCUTANEOUS |
| Original Marketing Date: | 18-06-2009 |
| Category Name: | BLA |
| Application Number: | BLA125319 |
| Labeler: | NOVARTIS PHARMACEUTICALS CORPORATION |
| Substance Name: | CANAKINUMAB |
| Active Numerator Strength: | 150 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | |
| DEA Schedule: |